Kyntra Bio (KYNB) Operating Leases (2020 - 2024)
Kyntra Bio (KYNB) posted Operating Leases of $2.0 million for Q3 2024, down 96.57% sequentially from $58.4 million in Q2 2024, and down 97.14% YoY from $70.0 million in Q4 2023.
Kyntra Bio (KYNB) Operating Leases (2020 - 2024) Analysis & Trends
Kyntra Bio has reported Operating Leases for 5 years, with the latest figure at $2.0 million in Q3 2024.
- Quarterly Operating Leases fell 97.14% year-over-year to $2.0 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $2.0 million (down 97.14% YoY) and the FY2023 annual result came in at $65.0 million, down 18.29% from the prior year.
- Operating Leases slipped to $2.0 million in Q3 2024 per KYNB's latest filing, from $58.4 million in the prior quarter.
- Over five years, Operating Leases peaked at $94.2 million in Q2 2021 and troughed at $678000.0 in Q1 2020.
- A 5-year average of $63.8 million and a median of $75.3 million in 2023 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2024: Operating Leases surged 2462.55% in 2022, then tumbled 97.14% in 2024.
- Over 5 years, Operating Leases stood at $678000.0 in 2020, then soared by 13460.91% to $91.9 million in 2021, then dropped by 13.43% to $79.6 million in 2022, then fell by 18.29% to $65.0 million in 2023, then plunged by 96.92% to $2.0 million in 2024.
- According to Business Quant data, Operating Leases over the past three periods registered $2.0 million, $58.4 million, and $62.5 million for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Kyntra Bio | 30.42 Mn | 30.42 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 58.38 Mn |
| Mar 31, 2024 | 62.51 Mn |
| Dec 31, 2023 | 65.03 Mn |
| Sep 30, 2023 | 70.04 Mn |
| Jun 30, 2023 | 73.81 Mn |
| Mar 31, 2023 | 76.89 Mn |
| Dec 31, 2022 | 79.59 Mn |
| Sep 30, 2022 | 81.09 Mn |
| Jun 30, 2022 | 83.08 Mn |
| Mar 31, 2022 | 85.95 Mn |
| Dec 31, 2021 | 91.94 Mn |
| Sep 30, 2021 | 91.48 Mn |
| Jun 30, 2021 | 94.20 Mn |
| Mar 31, 2021 | 3.35 Mn |
| Mar 31, 2020 | 678,000.00 |